Double-blind placebo-controlled study of cisapride in patients with nonspecific esophageal motility disorder accompanied by delayed esophageal transit

Scandinavian Journal of Gastroenterology

Volumn 32, Issue 6, 1997, Pages 541-546

  Song, C W ^a,b   Um, S H ^a   Kim, C D ^a   Ryu, H S ^a   Hyun, J H ^a   Choe, J G ^a  

^a Korea University Ansan Hospital   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

Cisapride; Esophageal motility disorder; Esophageal peristalsis; Esophageal transit; Nonspecific esophageal motility disorder

Indexed keywords

CISAPRIDE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; ESOPHAGUS FUNCTION DISORDER; ESOPHAGUS MANOMETRY; ESOPHAGUS MOTILITY; ESOPHAGUS SCINTISCANNING; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030785773     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529709025096     Document Type: Article

References (26)

1. Vantrappen G, Janssens J, Hellemans J, Coreman G. Achalasia, diffuse esophageal spasm and related motility disorders. Gastroenterology 1979;76:450-9.
2. Clouse RE, Staiano A. Contraction abnormalities of the esophageal body in patients referred for manometry; a new approach to manometric classification. Dig Dis Sci 1983;28: 784-91.
3. Castell DO. The nutcracker esophagus and other primary esophageal motility disorders. In: Castell DO, Richter JE, Dalton CB, editors. Esophageal motility testing. New York: Elsevier, 1987:1311-42.
4. Trube M, Peterson J, Siskind BN, McCallum RW. 'Segmental aperistalsis' of the esophagus; a cause of chest pain and dysphagia. Am J Gastroenterol 1988;83:1381-5.
5. Hsu JJ, O'Connor MK, Kang YW, Kim CH. Nonspecific motor disorder of the esophagus; a real disorder or a manometric curiosity? Gastroenterology 1993;104;1281-4.
6. Song CW, Kim CD, Ryu HS, Hyun JH. Esophagoparesis as a candidate for a new esophageal motility disorder. Gut 1994; 35:187.
7. Song CW, Kim CD, Hyun JH. Esophageal manometry in 70 healthy Koreans. Korean J Med 1944;47:803-11.
8. Choe JG, Lee MJ, Song CW. Radionuclide esophageal transit study in the esophageal motility disorder. Korean J Nucl Med 1993;27:233-8.
9. On DJ, Richter JE, Chen YM, Wu Wc, Gelfand DW, Castell DU. Esophageal radiography and manometry: correlation in 172 patients with dysphagia. AJR 1987;249:307-11.
10. Katz PO, Dalton CB, Richter JE, Wu WC, Castell DO. Esophageal testing of patients with noncardiac chest pain or dysphagia. Am Int Med 1987;106:593-7.
11. Leite L, Johnston B, Barrett J, Castell D. Non-specific esophageal motility disorder (NEMO) is primarily ineffective esophageal motility (IEM). Gastroenterology 1995:AZ26.
12. Rösch W. Cisapride in non-ulcer dyspepsia. Scand J Gastroenterol 1987;22:161-4.
13. Ceccatelli P, Janssens J, Vantrappen G, Cucchiara S. Cisapride restores the decreased lower esophageal sphincter pressure in reflux patients and healthy volunteers. A double-blind cross-over study. Gut 1988;29:631-5.
14. Jian R, Ducrot F, Piedeloup C, Mary JY, Najean Y, Bernier JJ. Measurement of gastric emptying in dyspeptic patients; effect of a new gastrokinetic agent (cisapride). Gut 1985;26:352-8.
15. Krevsky B, Malmud LS, Maurer AH, Somers MB, Siegal JA, Fisher RS. The effect of oral cisapride on colonie transit. Aliment Pharmacol Ther 1987;1:293-304.
16. Lederer PC, Elleman A, Ludwig S, Lux G. Effects of cisapride (C) and metoclopramide (M) on antroduodenal motor activity in man. Gastroenterology 1985;88:1468.
17. Camilleri M, Malagelada JR, Abell TL, Brown ML, Hench V, Zinsmeister AE. Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudo-obstruction. Gastroenterology 1989;96:704-12.
18. Horowitz M, Maddern GJ, Maddox A, Wishart J, Chatterton BE, Shearman DJ. Effect of cisapride on gastric and esophageal emptying in progressive systemic sclerosis. Gastroenterology 1987;93:311-5.
19. Horowitz M, Maddox A, Wishart J, Collins PJ, Shearman DJC. The effects of cisapride on gastric and esophageal emptying in dystrophia myotonica. J Gastroenterol Hepatol 1987;2:285-93.
20. Eriksen CA, Sutton D, Kennedy N, Cushieri A. Effect of cisapride on oesophageal transit: results of a retrospectively randomised clinical trial. Gullet; 1090; 1:31-5.
21. Fass J, Silny J, Braun J, Heindrichs U, Dreuw B, Schumpelick V, et al. Measuring esophageal motility with a new intraluminal impedance device. First clinical results in reflux patients. Scand J Gastroenterol 1994;29:693-702.
22. Kim CH, Hsu JJ, O'Connor MK, Weaver AL, Brown ML, Zinsmeister AR. Effect of viscosity on oropharyngeal and esophageal emptying in man. Dig Dis Sci 1994;39:189-92.
23. Dooley CP, Sholssmacher B, Velenzuela JE. Effects of alterations in bolus viscosity on esophageal peristalsis in humans. Am J Physiol 1988;254:G8-11.
24. Keren S, Argaman E, Golan M. Solid swallowing versus water swallowing: manometric study of dysphagia. Dig Dis Sci 1992; 37:603-8.
25. Howard PJ, Pryde A, Heading RC. Oesophageal manometry during eating in the investigation of patients with chest pain or dysphagia. Gut 1989;30:1179.
26. Kendall GPN, Thompson DO, Day SJ, Garvie N. Motor responses of the oesophagus to intraluminal distension in normal subjects and patients with oesophageal clearance disorders. Gut 1987;28:272.